Similarly, the findings of this study revealed that GC with a glycolytic phenotype had higher inflammation and a lower ERBB2 expression level, which was consistent with the role of glycolysis in tumour aggressiveness and the inflammatory milieu in GC. Here, ERBB2 is linked to gastric cancer.